lysine has been researched along with DDD MPGNII in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gilkeson, GS; Hofbauer, AF; Njoku, C; Oates, JC; Ruiz, P; Self, SE | 1 |
Heinen, S; Hoppe, B; Józsi, M; Kirschfink, M; Licht, C; Löschmann, I; Perkins, SJ; Saunders, RE; Skerka, C; Waldherr, R; Zipfel, PF | 1 |
2 other study(ies) available for lysine and DDD MPGNII
Article | Year |
---|---|
Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene.
Topics: Animals; Antibodies, Antinuclear; Disease Models, Animal; Enzyme Inhibitors; Female; Glomerulonephritis, Membranoproliferative; Lupus Nephritis; Lysine; Male; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Mice, Knockout; Nitric Oxide Synthase Type II; Proteinuria | 2008 |
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).
Topics: Amino Acid Sequence; Child; Complement C3 Nephritic Factor; Complement Factor H; Complement Pathway, Alternative; Consanguinity; Female; Glomerulonephritis, Membranoproliferative; Humans; Lysine; Molecular Sequence Data; Pedigree; Plasma; Protein Structure, Tertiary; Sequence Deletion | 2006 |